Predicting survival of pancreatic cancer patients treated with gemcitabine using longitudinal tumour size data

PURPOSE: Measures derived from longitudinal tumour size data have been increasingly utilised to predict survival of patients with solid tumours. The aim of this study was to examine the prognostic value of such measures for patients with metastatic pancreatic cancer undergoing gemcitabine therapy. M...

Descripción completa

Detalles Bibliográficos
Autores principales: Wendling, Thierry, Mistry, Hitesh, Ogungbenro, Kayode, Aarons, Leon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4844653/
https://www.ncbi.nlm.nih.gov/pubmed/26940939
http://dx.doi.org/10.1007/s00280-016-2994-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4844653/
https://www.ncbi.nlm.nih.gov/pubmed/26940939
http://dx.doi.org/10.1007/s00280-016-2994-x

Ejemplares similares